Literature DB >> 17189223

Sacroiliitis as an initial manifestation of acute myelogenous leukemia.

Takumi Hoshino1, Takafumi Matsushima, Yasuyuki Saitoh, Arito Yamane, Makiko Takizawa, Hiroyuki Irisawa, Takayuki Saitoh, Hiroshi Handa, Norifumi Tsukamoto, Masamitsu Karasawa, Hirokazu Murakami, Yoshihisa Nojima.   

Abstract

Sacroiliitis is the most pathognomonic and earliest manifestation of ankylosing spondylitis. We herein report a 28-year-old female patient who presented with sacroiliitis as an initial manifestation of acute myelogenous leukemia (AML). She had a 3-month history of anemia and walking difficulty. Bone marrow findings revealed an increase of blasts with trilineage dysplasia. Although she was initially diagnosed with myelodysplastic syndrome (MDS), blasts rapidly increased and AML developed 1 month after the diagnosis of MDS with Sacroiliitis. Induction chemotherapy failed to induce a complete remission of AML, but it did effectively treat the sacroiliitis. However, the sacroiliitis relapsed when the leukemia cells progressed thereafter. Oral corticosteroids helped ameliorate the sacroiliitis. She underwent bone marrow transplantation (BMT) from an HLA-identical sister during a nonremission period; however, the leukemic cells began to rapidly increase from day 30 after BMT. The close relationship between the occurrence of sacroiliitis and AML suggested that autoimmune sacroiliitis was a paraneoplastic phenomenon of AML in this patient. Although autoimmune disorders develop in a substantial number of MDS patients, they are rarely observed in de novo AML. No previous report has described sacroiliitis as the initial manifestation of de novo AML.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189223     DOI: 10.1532/IJH97.06106

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  13 in total

Review 1.  Rheumatic manifestations in myelodysplastic syndromes.

Authors:  M Castro; D L Conn; W P Su; J P Garton
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

2.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

3.  Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients.

Authors:  T Okamoto; M Okada; A Mori; K Saheki; H Takatsuka; H Wada; A Tamura; Y Fujimori; Y Takemoto; A Kanamaru; E Kakishita
Journal:  Int J Hematol       Date:  1997-10       Impact factor: 2.490

4.  Risk of haematological malignancies in HLA-B27 carriers.

Authors:  W Y Au; B R Hawkins; N Cheng; A K Lie; R Liang; Y L Kwong
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

5.  First manifestations of seronegative spondylarthropathy following autologous stem cell transplantation in HLA-B27-positive patients.

Authors:  B Koch; N Kranzhöfer; M Pfreundschu; H W Pees; L Trümper
Journal:  Bone Marrow Transplant       Date:  2000-09       Impact factor: 5.483

6.  Recurrent steroid-responsive pancreatitis associated with myelodysplastic syndrome and transformations.

Authors:  Tawee Tanvetyanon; Patrick J Stiff
Journal:  Leuk Lymphoma       Date:  2005-01

7.  Immune-mediated complications in patients with myelodysplastic syndromes--clinical and cytogenetic features.

Authors:  R Billström; H Johansson; B Johansson; F Mitelman
Journal:  Eur J Haematol       Date:  1995-07       Impact factor: 2.997

8.  Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.

Authors:  H Enright; H S Jacob; G Vercellotti; R Howe; M Belzer; W Miller
Journal:  Br J Haematol       Date:  1995-10       Impact factor: 6.998

9.  Immune abnormalities in myelodysplastic syndromes.

Authors:  T Economopoulos; J Economidou; G Giannopoulos; C Terzoglou; E Papageorgiou; J Dervenoulas; P Arseni; J Hadjioannou; S Raptis
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

10.  Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket.

Authors:  A Yamaguchi; N Tsuchiya; H Mitsui; M Shiota; A Ogawa; K Tokunaga; S Yoshinoya; T Juji; K Ito
Journal:  Arthritis Rheum       Date:  1995-11
View more
  5 in total

1.  Acute lymphocytic leukemia mimicking spondyloarthritis in an adolescent: A case report and review of the literature.

Authors:  Danyi Xu; Guanhua Xu; Liqin Xu; Heng Cao; Bei Xu; Weiqian Chen; Chuanyin Sun; Lihuan Yue; Jin Lin
Journal:  Oncol Lett       Date:  2015-12-11       Impact factor: 2.967

2.  Ankylosing spondylitis in a patient with myelodysplastic syndrome: an association with HLA-B27 or coincidence?

Authors:  Jaejoon Lee; Hyungjin Kim; Joong Kyong Ahn; Ji Won Hwang; Jun Ho Jang; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Rheumatol Int       Date:  2008-10-09       Impact factor: 2.631

Review 3.  Acute sacroiliitis.

Authors:  Gleb Slobodin; Doron Rimar; Nina Boulman; Lisa Kaly; Michael Rozenbaum; Itzhak Rosner; Majed Odeh
Journal:  Clin Rheumatol       Date:  2016-02-04       Impact factor: 2.980

4.  Rheumatic manifestations as initial presentation of malignancy: A case series from a tertiary care center in India.

Authors:  Prasanta Padhan; Bhaskar Thakur; Pratima Singh; Ipsita Mohanty; Saroj Ranjan Sahoo
Journal:  Eur J Rheumatol       Date:  2018-12-13

5.  Concurrent ankylosing spondylitis and myelodysplastic syndrome: A case report.

Authors:  Guan-Hua Xu; Jin Lin; Wei-Qian Chen
Journal:  World J Clin Cases       Date:  2022-02-26       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.